152 related articles for article (PubMed ID: 24379071)
1. The impact of ultrasonographic lesion size and initial human chorionic gonadotropin values on treatment success in cases with complete hydatidiform mole.
Seckin KD; Baser E; Yeral I; Togrul C; Ozdal B; Gungor T
Eur Rev Med Pharmacol Sci; 2013 Dec; 17(24):3381-4. PubMed ID: 24379071
[TBL] [Abstract][Full Text] [Related]
2. Serial hCG and ultrasound measurements for predicting malignant potential in multiple pregnancies associated with complete hydatidiform mole: a report of 2 cases.
Steigrad SJ; Robertson G; Kaye AL
J Reprod Med; 2004 Jul; 49(7):554-8. PubMed ID: 15305827
[TBL] [Abstract][Full Text] [Related]
3. Earlier diagnosis and serum human chorionic gonadotropin regression in complete hydatidiform moles.
Kerkmeijer LG; Massuger LF; Ten Kate-Booij MJ; Sweep FC; Thomas CM
Obstet Gynecol; 2009 Feb; 113(2 Pt 1):326-31. PubMed ID: 19155902
[TBL] [Abstract][Full Text] [Related]
4. What is the optimal duration of human chorionic gonadotrophin surveillance following evacuation of a molar pregnancy? A retrospective analysis on over 20,000 consecutive patients.
Coyle C; Short D; Jackson L; Sebire NJ; Kaur B; Harvey R; Savage PM; Seckl MJ
Gynecol Oncol; 2018 Feb; 148(2):254-257. PubMed ID: 29229282
[TBL] [Abstract][Full Text] [Related]
5. [Analysis of prophylactic chemotherapy outcome and clinical characteristics in patients of high-risk hydatidiform mole].
Geng S; Feng FZ; Xiang Y; Wan XR; Zhou Y
Zhonghua Fu Chan Ke Za Zhi; 2011 Jan; 46(1):24-7. PubMed ID: 21429430
[TBL] [Abstract][Full Text] [Related]
6. Postmolar gestational trophoblastic neoplasia: beyond the traditional risk factors.
Bakhtiyari M; Mirzamoradi M; Kimyaiee P; Aghaie A; Mansournia MA; Ashrafi-Vand S; Sarfjoo FS
Fertil Steril; 2015 Sep; 104(3):649-54. PubMed ID: 26099850
[TBL] [Abstract][Full Text] [Related]
7. Gestational trophoblastic neoplasia after spontaneous human chorionic gonadotropin normalization following molar pregnancy evacuation.
Braga A; Maestá I; Matos M; Elias KM; Rizzo J; Viggiano MG
Gynecol Oncol; 2015 Nov; 139(2):283-7. PubMed ID: 26383828
[TBL] [Abstract][Full Text] [Related]
8. [Clinical characteristics and diagnosis of early hydatidiform mole].
Jiao LZ; You SY; Wang YP; Zhu CG; Jiang JY
Zhonghua Fu Chan Ke Za Zhi; 2019 Nov; 54(11):756-762. PubMed ID: 31752459
[No Abstract] [Full Text] [Related]
9. Plasma human chorionic gonadotropin disappearance in hydatidiform mole: a central registry report from the Netherlands.
Franke HR; Risse EK; Kenemans P; Houx PC; Stolk JG; Vooijs GP
Obstet Gynecol; 1983 Oct; 62(4):467-73. PubMed ID: 6888825
[TBL] [Abstract][Full Text] [Related]
10. Recurrent gestational trophoblastic disease after hCG normalization following hydatidiform mole in The Netherlands.
Kerkmeijer LG; Wielsma S; Massuger LF; Sweep FC; Thomas CM
Gynecol Oncol; 2007 Jul; 106(1):142-6. PubMed ID: 17462723
[TBL] [Abstract][Full Text] [Related]
11. Hydatidiform mole: clinical analysis of 310 patients.
Mungan T; Kuşçu E; Dabakoğlu T; Senöz S; Uğur M; Cobanoglu O
Int J Gynaecol Obstet; 1996 Mar; 52(3):233-6. PubMed ID: 8775674
[TBL] [Abstract][Full Text] [Related]
12. A prospective study of ultrasound screening for molar pregnancies in missed miscarriages.
Johns J; Greenwold N; Buckley S; Jauniaux E
Ultrasound Obstet Gynecol; 2005 May; 25(5):493-7. PubMed ID: 15818571
[TBL] [Abstract][Full Text] [Related]
13. Extraluminal hyperechogenic echo detected by transvaginal ultrasonography as a prognostic factor in recurrent hydatidiform mole.
Goshen R; Lavy Y; Hochner-Celnikier H; Yagel S
Gynecol Obstet Invest; 1992; 34(4):243-5. PubMed ID: 1283145
[TBL] [Abstract][Full Text] [Related]
14. Partial hydatidiform mole and coexisting viable twin pregnancy.
Tay ET
Pediatr Emerg Care; 2013 Dec; 29(12):1298-300. PubMed ID: 24300477
[TBL] [Abstract][Full Text] [Related]
15. Can circulating M30 and M65 levels be beneficial markers in the diagnosis and management of patients with complete hydatidiform mole?
Incebiyik A; Vural M; Camuzcuoglu H; Taskin A; Camuzcuoglu A; Hilali NG; Aksoy N
Wien Klin Wochenschr; 2016 Dec; 128(Suppl 8):566-571. PubMed ID: 25869758
[TBL] [Abstract][Full Text] [Related]
16. Inhibin as a marker for hydatidiform mole: a comparative study with the determinations of intact human chorionic gonadotrophin and its free beta-subunit.
Badonnel Y; Barbé F; Legagneur H; Poncelet E; Schweitzer M
Clin Endocrinol (Oxf); 1994 Aug; 41(2):155-62. PubMed ID: 7523000
[TBL] [Abstract][Full Text] [Related]
17. [Complete hydatiforme mole in Morocco: epidemiological and clinical study].
Boufettal H; Coullin P; Mahdaoui S; Noun M; Hermas S; Samouh N
J Gynecol Obstet Biol Reprod (Paris); 2011 Sep; 40(5):419-29. PubMed ID: 21458172
[TBL] [Abstract][Full Text] [Related]
18. Clinical features of multiple conception with partial or complete molar pregnancy and coexisting fetuses.
Steller MA; Genest DR; Bernstein MR; Lage JM; Goldstein DP; Berkowitz RS
J Reprod Med; 1994 Mar; 39(3):147-54. PubMed ID: 8035369
[TBL] [Abstract][Full Text] [Related]
19. Prognostic relevance of F-18 fluorodeoxyglucose positron emission tomography and computed tomography in molar pregnancy before evacuation.
Ak I; Ozalp S
J Reprod Med; 2009 Jul; 54(7):441-6. PubMed ID: 19691261
[TBL] [Abstract][Full Text] [Related]
20. Radiology rounds. Molar pregnancy (hydatidiform mole; gestational trophoblastic disease).
McLennan MK
Can Fam Physician; 1999 Jan; 45():49, 61-2. PubMed ID: 10889855
[No Abstract] [Full Text] [Related]
[Next] [New Search]
